Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa.

Chanda C, Kibengo F, Mutua M, Ogada F, Muturi-Kioi V, Akis Yildirim BM, Amondi M, Baines A, Basajja V, Borthwick N, Bosire K, Chambula E, Chetty P, Chinyenze K, Chirro O, Crook A, De Bont J, Fernandez N, Ejou P, Farah B, Glaze M, Gombe B, Gumbe A, Hayes P, Itwi S, Juma S, Kabarambi A, Kabengele C, Kafeero P, Kakande A, Kanungi J, Kidega W, King D, Mahira R, Malogo R, Matsoso M, Michelo C, Moyo A, Mugaba S, Mugenya I, Muhumuza P, Mujadidi YF, Muriuki M, Musale V, Mutua G, Muwowo M, Mwale F, Mwangi I, Nakimbugwe M, Namuyanja A, Nduati E, Nielsen L, Nyange J, Oino G, Okech B, Omosa-Manyonyi G, Otieno D, Palmer S, Phiri H, Ramko K, Rutishauser RL, Sayeed E, Sajabi R, Serwanga J, G-T Wee E, Wenden C, Cicconi P, Fast P, Gilmour J, Jaoko W, Kaleebu P, Kilembe W, Kuipers H, Sanders EJ, Hanke T

Open source

DOI: 10.1016/j.lanmic.2024.101041
Published: 2025 Jun
Container: The Lancet. Microbe
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.lanmic.2024.101041,
  title = {Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa.},
  author = {Chanda C and Kibengo F and Mutua M and Ogada F and Muturi-Kioi V and Akis Yildirim BM and Amondi M and Baines A and Basajja V and Borthwick N and Bosire K and Chambula E and Chetty P and Chinyenze K and Chirro O and Crook A and De Bont J and Fernandez N and Ejou P and Farah B and Glaze M and Gombe B and Gumbe A and Hayes P and Itwi S and Juma S and Kabarambi A and Kabengele C and Kafeero P and Kakande A and Kanungi J and Kidega W and King D and Mahira R and Malogo R and Matsoso M and Michelo C and Moyo A and Mugaba S and Mugenya I and Muhumuza P and Mujadidi YF and Muriuki M and Musale V and Mutua G and Muwowo M and Mwale F and Mwangi I and Nakimbugwe M and Namuyanja A and Nduati E and Nielsen L and Nyange J and Oino G and Okech B and Omosa-Manyonyi G and Otieno D and Palmer S and Phiri H and Ramko K and Rutishauser RL and Sayeed E and Sajabi R and Serwanga J and G-T Wee E and Wenden C and Cicconi P and Fast P and Gilmour J and Jaoko W and Kaleebu P and Kilembe W and Kuipers H and Sanders EJ and Hanke T},
  year = {2025},
  journal = {The Lancet. Microbe},
  doi = {10.1016/j.lanmic.2024.101041},
  url = {https://doi.org/10.1016/j.lanmic.2024.101041}
}

RIS

TY  - JOUR
TI  - Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa.
AU  - Chanda C
AU  - Kibengo F
AU  - Mutua M
AU  - Ogada F
AU  - Muturi-Kioi V
AU  - Akis Yildirim BM
AU  - Amondi M
AU  - Baines A
AU  - Basajja V
AU  - Borthwick N
AU  - Bosire K
AU  - Chambula E
AU  - Chetty P
AU  - Chinyenze K
AU  - Chirro O
AU  - Crook A
AU  - De Bont J
AU  - Fernandez N
AU  - Ejou P
AU  - Farah B
AU  - Glaze M
AU  - Gombe B
AU  - Gumbe A
AU  - Hayes P
AU  - Itwi S
AU  - Juma S
AU  - Kabarambi A
AU  - Kabengele C
AU  - Kafeero P
AU  - Kakande A
AU  - Kanungi J
AU  - Kidega W
AU  - King D
AU  - Mahira R
AU  - Malogo R
AU  - Matsoso M
AU  - Michelo C
AU  - Moyo A
AU  - Mugaba S
AU  - Mugenya I
AU  - Muhumuza P
AU  - Mujadidi YF
AU  - Muriuki M
AU  - Musale V
AU  - Mutua G
AU  - Muwowo M
AU  - Mwale F
AU  - Mwangi I
AU  - Nakimbugwe M
AU  - Namuyanja A
AU  - Nduati E
AU  - Nielsen L
AU  - Nyange J
AU  - Oino G
AU  - Okech B
AU  - Omosa-Manyonyi G
AU  - Otieno D
AU  - Palmer S
AU  - Phiri H
AU  - Ramko K
AU  - Rutishauser RL
AU  - Sayeed E
AU  - Sajabi R
AU  - Serwanga J
AU  - G-T Wee E
AU  - Wenden C
AU  - Cicconi P
AU  - Fast P
AU  - Gilmour J
AU  - Jaoko W
AU  - Kaleebu P
AU  - Kilembe W
AU  - Kuipers H
AU  - Sanders EJ
AU  - Hanke T
PY  - 2025
JO  - The Lancet. Microbe
DO  - 10.1016/j.lanmic.2024.101041
UR  - https://doi.org/10.1016/j.lanmic.2024.101041
ER  -

APA

C, C., F, K., M, M., F, O., V, M., BM, A. Y., M, A., A, B., V, B., N, B., K, B., E, C., P, C., K, C., O, C., A, C., J, D. B., N, F., P, E., B, F., M, G., B, G., A, G., P, H., S, I., S, J., A, K., C, K., P, K., A, K., J, K., W, K., D, K., R, M., R, M., M, M., C, M., A, M., S, M., I, M., P, M., YF, M., M, M., V, M., G, M., M, M., F, M., I, M., M, N., A, N., E, N., L, N., J, N., G, O., B, O., G, O., D, O., S, P., H, P., K, R., RL, R., E, S., R, S., J, S., E, G. W., C, W., P, C., P, F., J, G., W, J., P, K., W, K., H, K., EJ, S., & T, H. (2025). Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa.. The Lancet. Microbe. https://doi.org/10.1016/j.lanmic.2024.101041

Source records

pubmed · retrieved 2026-09-25T10:40:11.938Z